Quick Answer
NEUROCRINE BIOSCIENCES INC reported Net Income of $478.60 million for fiscal year 2025.
NEUROCRINE BIOSCIENCES INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $478.60M | +40.2% |
| 2024 | $341.30M | +36.7% |
| 2023 | $249.70M | +61.6% |
| 2022 | $154.50M | +72.4% |
| 2021 | $89.60M | -78.0% |
| 2020 | $407.30M | +1000.8% |
| 2019 | $37.00M | +75.4% |
| 2018 | $21.10M | +114.8% |
| 2017 | -$142.54M | -1.0% |
| 2016 | -$141.09M | -58.7% |
| 2015 | -$88.93M | -46.9% |
| 2014 | -$60.54M | -31.4% |
| 2013 | -$46.09M | -1017.2% |
| 2012 | $5.03M | -86.6% |
| 2011 | $37.57M | +571.5% |
| 2010 | -$7.97M | +84.4% |
| 2009 | -$51.04M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $209.50M | +61.4% | +94.9% |
| June 30, 2025 | $107.50M | +65.4% | +1260.8% |
| March 31, 2025 | $7.90M | -81.8% | -93.9% |
| September 30, 2024 | $129.80M | +56.2% | +99.7% |
| June 30, 2024 | $65.00M | -31.9% | +49.8% |
| March 31, 2024 | $43.40M | +156.7% | -47.8% |
| September 30, 2023 | $83.10M | +21.3% | -13.0% |
| June 30, 2023 | $95.50M | +665.1% | +224.7% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +40.2% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, NEUROCRINE BIOSCIENCES INC’s net income has grown by 1037.7% (from -$51.04 million to $478.60 million).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: